Eight months ago, a genetically modified virus (PRX-32) escaped quarantine from a vision research centre in Switzerland. With the ability to modify the infected host and alter brain function, the virus began to spread at an unprecedented rate. Authorities are yet to release details on the quarantine zone, but the CDC has implemented level 5 isolation procedures in towns up to 400 miles from 'ground zero'.
Working on a cure for blindness and color blindness, the research centre used a viral delivery technique to implant photo receptor genes in the subject. It is believed there has been an activation of the virus due to a mutation between the receptor genes and the virus DNA. Opponents of viral technology have cited such risks as far in excess of the good any research can offer. With a potentially deadly new virus moving through Switzerland, Swiss authorities are slow to release any information on either the research centre personnel or the infection vector, leaving the whole of Europe in a state of anxiety and fear.